Enjoy complimentary customisation on priority with our Enterprise License!
The global preclinical animal telemetry market size is estimated to grow by USD 21.55 million at a CAGR of 5.69% between 2023 and 2028.
As a part of organic growth strategies, companies are increasingly focusing on new feature integration, as well as product development and launches. The launch of new products is allowing companies to remain competitive in the market by offering the latest available technologies to their customers. Additionally, companies can efficiently meet the specific demands of end-users by bringing innovative changes in their product lineup as per customers' expectations. Some of the recent product launches have been discussed below: Since 2021, the US Animal Telemetry Network (ATN) has been attempting to integrate ocean profiles obtained from animal-borne satellite telemetry tags, including the Wildlife Computers SCOUT-CTD, into the World Meteorological Organizations Global Telecommunication System. Such constant improvements and upgrades in features have brought significant differentiation in products and have helped companies lower the competition and increase product penetration. Therefore, an increase in product launches of preclinical animal telemetry is driving the market growth during the forecast period.
Technavio has segmented the market into End-user, Type, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the industrial laboratories and CROs segment will be significant during the forecast period. Industrial laboratories (including pharmaceutical and biotechnology companies) and CROs are among the key organizations involved in drug discovery, research, design, and development. These organizations spend a considerable number of resources and time in preclinical and clinical research for advancing new therapeutic candidates.
Get a glance at the market contribution of various segments Download PDF Sample
The Industrial laboratories and CROs were the largest segment and were valued at USD 32.41 million in 2018. Further, the increase in patent expiries of blockbuster drugs and biologicals has led to an increased focus on R&D activities. As a result, pharmaceutical and biotechnology companies are increasingly promoting the outsourcing of clinical research to CROs. This led to the outsourcing of R&D activities for developing new formulations. To reduce the risk of adverse events during clinical trials of these new formulations, the demand for preclinical animal testing, including toxicology testing and cosmetic testing, has increased. Animal telemetry solutions are finding extensive use for collecting and analyzing a large amount of preclinical safety and efficacy data. This preclinical safety and efficacy data is required to be submitted to drug regulatory authorities before permission for further studies in humans is granted. As a result, significant demand for preclinical animal research and testing can be observed across industrial laboratories and CROs globally, which is driving the adoption of animal telemetry systems, which, in turn, will drive the growth of the market during the forecast period.
The small animal telemetry segment includes animal telemetry solutions that are used in preclinical research with small animals such as mice, rabbits, ferrets, rats, hamsters, and Guinea pigs. Small animal telemetry solutions are usually miniaturized telemetry implants that are small in size and lightweight and can be custom-configured and modified as per the research and testing requirements. Furthermore, the availability of cost-effective, minimally invasive, wireless battery charging-based, flexible telemetry systems is adding to the growing sales of small animal telemetry systems. The market is expected to witness swift growth owing to stringencies in regulations for maintaining pharmacological safety and the growing availability of funding for research related to neuroscience, cardiology, and oncology.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America dominates the global preclinical animal telemetry market, with the US and Canada as leading revenue-generating countries. Increasing growth in drug and vaccine approvals and growth in investments for drug research and development surged the demand for animal testing during preclinical studies. As a result, the demand for animal telemetry systems witnessed significant growth in the region. Furthermore, the presence of a large number of prominent players, such as BIOPAC Systems, Indus Instruments, Harvard Biosciences, Somark Innovations, TSE Systems GMBH, Starr Life Sciences Corp., and Transonic, helped in ensuring the easy availability of advanced telemetry solutions among end-users.
Furthermore, the exceptional veterinary-specific equipment offered by Mindray Animal Medical ranges from the ePM series monitors or the TM80 Vet telemetry to a central station for vital sign monitoring, the Veta 5 and WATO series anesthesia station with integrated ventilators, and the BeneFusion VP3 Vet and BeneFusion SP3 Vet fluid pumps. These products are designed to support and elevate standards in animal health care. Therefore such factors are expected to drive the regional market growth during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
ADInstruments Pty Ltd.: The company offers preclinical animal telemetry for the wireless recording of a variety of biological signals in small animals under its brand Kaha Sciences.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market research and growth analysis. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges.
Increasing growth in preclinical research and testing is notably driving the market growth. The rising prevalence of diseases such as cardiovascular diseases, endocrine and metabolic disorders, cancer, and diabetes across the globe has stimulated the demand for the development of efficient and effective therapeutics. As a result, increasing market growth and trends in preclinical and clinical research activities across pharmaceutical companies and CROs can be observed. Furthermore, the competition among drug developers is high, and to gain a competitive edge, these organizations are rapidly adopting advanced and automated workflows in their routine processes.
Thus, the demand for animal telemetry systems in preclinical research has increased. These systems offer automated and real-time monitoring of the physiological activities of small and large animal models. Such capabilities are enhancing drug development studies and are ensuring the rapid development of drugs, thereby driving the adoption of animal telemetry solutions among pharmaceutical companies and CROs. Thus, such factors will drive the growth of the market during the market forecast period.
Growing focus on developing SEND-compatible software is an emerging trend shaping the market growth. Modifications in US FDA regulatory requirements for data submission have brought significant changes across product lines since January 2019. To overcome inconsistencies in data formats and to define standard data format for nonclinical data presentation, the US FDA has mandated the use of the Standard of Exchange of Nonclinical Data (SEND) format, which specifies a way to present nonclinical data. Further, the availability of easy report-generating capabilities in a defined SEND format allows end-users to comply with defined standards for submitting preclinical data to the US FDA quickly and without manual efforts.
As a result, the demand for software that supports SEND-compatible output has increased among end-users. Thus, the growing focus on developing SEND-compatible software will drive the growth of the global preclinical animal telemetry market during the forecast period.
Limitations associated with animal telemetry systems are a significant challenge hindering market growth. Animal telemetry systems are extensively used in preclinical studies as an advanced and innovative technique for physiological monitoring and data collection of animal models. However, these systems have certain technical challenges and limitations which hamper their sales. Some of the common issues are the limited battery life of telemetric implants, poor design and scalability, bandwidth-related issues, and the lack of compatibility. Furthermore, the integration of animal telemetry hardware and software into the existing systems of laboratories is another challenge. A laboratory may operate different kinds of systems, including computers and laboratory equipment, which may not be compatible with advanced offerings from vendors.
However, such laboratory settings prefer the use of conventional systems, which lowers the adoption of new and improved systems, thereby hampering the sales of new animal telemetry systems. Thus, limitations associated with animal telemetry systems will hamper the growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Global Preclinical Animal Telemetry Market Customer Landscape
The preclinical animal telemetry market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and market growth and forecasting opportunities from 2018 to 2028.
Preclinical Animal Telemetry Market Scope |
|
Report Coverage |
Details |
Page number |
152 |
Base year |
2023 |
Historic period |
2018-2022 |
Market forecasting period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.69% |
Market Growth 2024-2028 |
USD 21.55 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.86 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 44% |
Key countries |
US, UK, Germany, France, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
ADInstruments Pty Ltd., Advanced Telemetry Systems Inc., BIO RESEARCH CENTER Co. Ltd., BIOPAC Systems Inc., Cambridge NeuroTech, Charles River Laboratories International Inc., Ecotone Goc, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Indus Instruments, Instem Plc, Kent Scientific Corp., Muromachi Kikai Co. Ltd., Somark Innovations, Star Oddi hf, Starr Life Sciences Corp., Telemetry Solutions Inc., TSE Systems GmbH, and Vivonics Preclinical Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
Detailed information on factors that will drive the growth of the preclinical animal telemetry market between 2024 and 2028
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.